Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Current Pharmaceutical Design|November 11, 2008
Imaging of tumor hypoxia to predict treatment sensitivityH Minn, T J Grönroos, G Komar, et al.Neuroscience Letters|September 25, 2001
Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleusA Brück, R Portin, A Lindell, et al.Synapse (New York, N.Y.)|February 19, 1999
Striatal uptake of a novel PET ligand, [18F]beta-CFT, is reduced in early Parkinson's diseaseJ O Rinne, J Bergman, H Ruottinen, et al.Diabetes|September 1, 1997
Myocardial glucose uptake in patients with NIDDM and stable coronary artery diseaseM Mäki, P Nuutila, H Laine, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Pharmacokinetics of [18F]FETNIM: a potential marker for PETT Grönroos, O Eskola, K Lehtiö, et al.Acta Physiologica Scandinavica|May 1, 1994
Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomographyG Blomqvist, R J Seitz, I Sjögren, et al.Journal of Neuroscience Research|December 1, 1990
PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's diseaseJ O Rinne, A Laihinen, K Någren, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Estimated radiation dose to the newborn in FDG-PET studiesU Ruotsalainen, H Suhonen-Polvi, E Eronen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1997
[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosisH M Ruottinen, J O Rinne, M Haaparanta, et al.The Journal of Clinical Investigation|April 16, 1998
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesityH Laine, H Yki-Jarvinen, O Kirvela, et al.Pageof 8